Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
hunimed.eu
IT
EN
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Competenze
☰
Pubblicazioni
THE LANCET ONCOLOGY
Rivista
Codice:
E098908
ISSN:
1470-2045
Dati Generali
Dati Generali
Pubblicazioni (74)
Pulisci
Ordina Pubblicazioni:
crescente
decrescente
A risk management approach for imaging biomarker-driven clinical trials in oncology
Articolo
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer(ASCEND-1): update results from the multicenter, open-label, phase 1 trial.
Articolo
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomized, double-blind, placebo-controlled, multicenter, phase 3 trial
Articolo
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Articolo
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Articolo
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Articolo
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up
Articolo
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Articolo
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
Articolo
Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study
Articolo
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis : a longitudinal study
Articolo
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Articolo
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Articolo
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Articolo
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Articolo
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Articolo
Clarifying the consensus on laryngeal preservation strategies – Authors' reply
Articolo
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE 0-28): preliminary results from non-randomised, open-label, phase 1b trial
Articolo
Consensus on molecular imaging and theranostics in prostate cancer
Articolo
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
Recensione
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
Articolo
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Articolo
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Articolo
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
Articolo
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy
Articolo
F-18-FDG PET/CT scans for children and adolescents
Articolo
Focal HIFU for prostate cancer.
Articolo
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma
Articolo
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Articolo
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
Articolo
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Articolo
Immunotherapy plus tyrosine-kinase inhibitors in hepatocellular carcinoma
Articolo
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Articolo
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study
Articolo
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
Recensione
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Articolo
Intramedullary spinal metastasis from ovarian cancer
Articolo
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Articolo
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer
Abstract
Lurbinectedin as a second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
Articolo
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
Articolo
More evidence for implant-based breast reconstruction
Articolo
Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
Articolo
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy:a randomised, placebo-controlled, double-blind study.
Articolo
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicenter, multicohort, single-arm phase 2 trial
Articolo
Novel trial designs for high-risk myelodysplastic syndromes.
Articolo
Nuclear medicine theranostics comes of age
Articolo
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomized, double-blind, placebo-controlled, phase 3 trial.
Articolo
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Articolo
PET-CT for response assessment and treatment adaptation in head and neck cancer
Articolo
Patient selection for immunotherapy in head and neck cancer
Articolo
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
Articolo
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
Articolo
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Recensione
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
Articolo
Quality of life after breast reconstruction-the BRIOS study
Articolo
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study
Articolo
RAMES study: is there really a role for VEGF inhibition in mesothelioma? – Authors' reply
Articolo
REGATTA trial: a call for the USA and Europe
Articolo
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Articolo
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
Articolo
Sentinel-lymph-node mapping in endometrial cancer
Articolo
Sex as a predictor of response to cancer immunotherapy Reply
Articolo
Shaping the landscape of immune oncology in hepatocellular carcinoma
Articolo
Stereotactic radiosurgery for patients with brain metastases.
Articolo
Tailoring adjuvant treatment in patients with uterine cancer
Articolo
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomized, double-blind, phase 3 trial.
Articolo
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review
Articolo
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC)
Articolo
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomized, placebo-controlled phase 2 study.
Articolo
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia
Recensione
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
Articolo
Use of cancer chemopreventive phytochemicals as antineoplastic agents
Articolo
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
